Contact Us
|
Sitemap
About ISTA
Products
Pipeline
Careers
Investors
BEPREVE
®
(bepotastine besilate
ophthalmic solution) 1.5%
Xibrom
(bromfenac ophthalmic
solution)
®
0.09%
Istalol
®
(timolol maleate
ophthalmic solution) 0.5%
Investor Highlights
Presentations
Stock Quotes
Quarterly Fact sheet
Products
BEPREVE
Xibrom
Istalol
Vitrase
Press Releases
ISTA Pharmaceuticals to Present at the Stifel Nicolaus Healthcare Conference 2010
ISTA Pharmaceuticals Reports Second Quarter 2010 Financial Results
ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2010 Financial Results